Company / Cash per Share
INOVIO PHARMACEUTICALS, INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.23
FY2025
5-year range
$0.21 / $2.89
FY2021-FY2025
Trend
-57.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 10 years, ranging from $0.21 in FY2022 to $2.89 in FY2024.
Based on SEC 10-K filings.
1.23 in FY2025 with a 5-year CAGR of -13.1%.
Improved from $0.68 to $1.23 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +79.2%
- 5-Year CAGR
- -13.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 57.5% year-over-year.
- Peak cash per share was recorded in FY2024.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.23 | -57.5% |
| FY2024 | $2.89 | +325.5% |
| FY2023 | $0.68 | +218.4% |
| FY2022 | $0.21 | -44.0% |
| FY2021 | $0.38 | -84.6% |
| FY2020 | $2.47 | +983.5% |
| FY2019 | $0.23 | -12.9% |
| FY2018 | $0.26 | -66.3% |
| FY2017 | $0.78 | +38.6% |
| FY2016 | $0.56 | +1.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026